Germany's healthcare landscape is shifting at a speed unseen in a generation, as the government confronts a series of challenges in modernising a healthcare market known for its strong interest and advocacy groups and its resistance to reform.
The UK’s for-profit ophthalmology sector is heating up, with multiple groups likely to come up for sale this year. This is being driven by the long term increase in the amount of cataract surgeries the NHS is outsourcing. Meanwhile deal activity in Germany’s sector is still on pause, due to a decrease in cataract surgery post Covid.
This infographic showcases Europe's top 5 ophthalmology players by revenue in the reporting period 2018–2022: Veonet Group, Sanoptis, Artemis Augenkliniken, Clinica Baviera, and Optegra.
Log My Care, a digital platform care management platform, has secured £3 million in funding from Mercia Ventures. This new investment boosts the company's total funding to over £7 million, and is not Mercia Ventures’ first investment in the business.
PE firm Nordic Capital has decided not to sell German nursing home group Alloheim, and instead to refinance it. Nordic Capital says it wants to hold onto the group “for the foreseeable future”.
Investment firms Swiss Life Asset Managers and Vesper Infrastructure Partners have acquired RAD-x, a diagnostic imaging platform operating in Germany and Switzerland. The deal is the latest in a series of major acquisitions by infrastructure funds within the diagnostics and medical imaging segment.
US-based PE firms Advent International and Carlyle Group are reportedly interested in bidding for Sanecum, a doctor-led network of outpatient clinics focused on internal medicine in Germany. If it goes ahead the sale could value the group at around €1.5bn.
Doctors are becoming increasingly interested in setting up clinics and running them as proper businesses. We spoke to Romesh Angunawela, who has recently completed an MBA especially for physicians in the US, and is the co-founder of OCL Vision, a three-clinic ophtha group in the UK. He shared his view on this trend and the factors driving it.
Consolidation has been the primary way that PE-backed private health care groups have grown in Europe. A lot of the low hanging fruit has now been picked. But canny investors are adopting new models to open up new consolidation opportunities.
AMEOS Gruppe, Germany’s fourth largest hospital group by revenue, has opened a medical campus in Halberstadt, Saxony-Anhalt, to provide the clinical stage of medical degrees for 40 doctors a years, as part of a degree program which AMEOS has been running for the past three years in partnership with a Croatian university.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy